We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





KaiMi Biotech Highlights First of Its Kind Color-Changing Swabs

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: QiDix color-changing swabs (Photo courtesy of KaiMi Biotech)
Image: QiDix color-changing swabs (Photo courtesy of KaiMi Biotech)

KaiMi Biotech (Jiangsu, China) is highlighting its innovative Unow multiplexing drug tests and first-of-its-kind QiDix color-changing swabs at MEDICA 2023.

KaiMi Biotech has launched a series of breakthrough Unow multiplexing drug tests based on its proprietary user-friendly Unow technology platform. These innovative drug tests offer several unprecedented advantages over existing drug tests available in the market to meet the long unmet needs of users. The tests need only a small quantity of saliva sample (80 ml) and a short sampling time (2s) to provide user convenience. A color-appearing indicator tells users if enough saliva has been collected to give them confidence and prevent test inconsistency as a result of sampling errors.

The Unow multiplexing drug tests can be run by a single hand with fewer steps than existing commercial tests and the results can be obtained in 5-10 minutes. Integrated running buffers in the test devices eliminate direct user contact with liquid diluent and reduce potential contamination. The US FDA-approved and CE-marked tests offer excellent detection sensitivity for all the common drugs of abuse that meets the standard cutoffs for most regions around the world. The tests offer great flexibility for customization for detecting different combinations of drugs in a single device to meet the customer’s specific needs.

At MEDICA 2023, KaiMi is also presenting its flagship product, the QiDix color-changing swabs. These swabs are immobilized with a proprietary color indicator to help users ensure that enough samples have been collected. The US FDA-approved QiDix swabs are particularly useful for collecting samples for babies and kids, or patients who have challenges collecting samples by themselves. The indicator can be triggered by body fluids such as saliva, nasal secretion, sweat, tears, and urine, but not by water. The color change will not fade once triggered and the color indicators consist of only safe food-grade ingredients. A number of types of QiDix swabs are available, ranging from flocked swabs, woven swabs, and cotton swabs.

Related Links:
KaiMi Biotech

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.